Abstract

Rationale and design for a phase II trial of abobotulinumtoxinA (Dysport®) in the management of vulvodynia

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call